Cargando…

Patients’ knowledge and attitudes to the Wise List - a drug formulary from the Stockholm Drug and Therapeutic committee

BACKGROUND: Involving patients in decisions about their pharmacotherapy is crucial for a satisfactory treatment outcome. Information and opinions about medicines are available from a variety of sources. The Wise List is the drug formulary of recommended essential medicines for the Stockholm healthca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bastholm-Rahmner, Pia, Gustafsson, Lars L., Aggefors, Kristina, Ateva, Kristina, Elfving, Susanne, Eriksen, Jaran, Jirlow, Malena, Juhasz-Haverinen, Maria, Malmström, Rickard E., Nikpour-Ardaly, Mahan, Röjvall, Magnus, Vallin, Martina, Andersén-Karlsson, Eva, Ovesjö, Marie-Louise
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848508/ https://www.ncbi.nlm.nih.gov/pubmed/29530028 http://dx.doi.org/10.1186/s12913-018-2968-2

Ejemplares similares

Primary care physicians report high trust in and usefulness of the Stockholm drug and therapeutic committee’s list of recommended essential medicines (the ‘Wise List’)
por: Eriksen, Jaran, et al.
Publicado: (2017)

High adherence to the ‘Wise List’ treatment recommendations in Stockholm: a 15-year retrospective review of a multifaceted approach promoting rational use of medicines
por: Eriksen, Jaran, et al.
Publicado: (2017)

A cross-sectional pilot study assessing needs and attitudes to implementation of Information and Communication Technology for rational use of medicines among healthcare staff in rural Tanzania
por: Nilseng, Jessica, et al.
Publicado: (2014)

Describing Sources of Uncertainty in Cancer Drug Formulary Priority Setting across Canada
por: Jenei, Kristina, et al.
Publicado: (2021)

Neonatal Drug Formularies—A Global Scope
por: Shaniv, Dotan, et al.
Publicado: (2023)

The U.S. Food and Drug Administration: Drug Information Resource for Formulary Recommendations
por: Marchand, Heidi C., et al.
Publicado: (2012)

A Prescription for Improving Drug Formulary Decision Making
por: Schiff, Gordon D., et al.
Publicado: (2012)

Impact of Formulary Restrictions on Antiepileptic Drug Dispensation Outcomes
por: Mehta, Darshan, et al.
Publicado: (2020)

Practice guidelines in the context of primary care, learning and usability in the physicians’ decision-making process – a qualitative study
por: Ingemansson, Maria, et al.
Publicado: (2014)

Clinical Monograph for Drug Formulary Review: Erectile Dysfunction Agents
por: Campbell, Helen Eloise
Publicado: (2005)

Reply to “Key Points to Consider When Evaluating Andexxa for Formulary Addition”
por: Mahan, Charles E.
Publicado: (2020)

Pediatricians’ Understanding and Experiences of an Electronic Clinical-Decision-Support-System
por: Nydert, Per, et al.
Publicado: (2017)

Family Physician attitudes about prescribing using a drug formulary
por: Suggs, L Suzanne, et al.
Publicado: (2009)

Drug Formulary Decisions - Evaluating the Risks and Benefits of Hormone Replacement Therapy
por: Curtiss, Frederic R.
Publicado: (2004)

Improving Patient Access to New Drugs in South Korea: Evaluation of the National Drug Formulary System
por: Yoo, Seung-Lai, et al.
Publicado: (2019)

Development of a computerised decisions support system for renal risk drugs targeting primary healthcare
por: Helldén, Anders, et al.
Publicado: (2015)

Effect of Patient Notification of Formulary Change on Formulary Adherence
por: Delate, Thomas, et al.
Publicado: (2005)

The veterinary formulary /
Publicado: (2001)

Pharmacopoeias and formularies
por: Earles, M P
Publicado: (1999)

The chemical formulary
Publicado: (1933)

The National Formulary
Publicado: (1955)

The Pocket Formulary
Publicado: (1852)

Dental Formulary
Publicado: (1911)

Formulary: Gonorrhœa
por: Roy, Don
Publicado: (1880)

Griffith’s Formulary
Publicado: (1874)

Reese’s Formulary
Publicado: (1850)

3-Tier Drug Benefit Designs Based on Sound Drug Formulary Principles Will Maximize Favorable Outcomes
por: Curtiss, Frederic R.
Publicado: (2004)

HTLV-2 infection still prevalent among older injecting drug users in Stockholm, Sweden – indications of limited spread to the younger generation
por: Malm, Kerstin, et al.
Publicado: (2011)

Evaluation of Prescription Adaptation Following Changes to A Provincial Drug Insurance Formulary
por: Pammett, Robert T.
Publicado: (2019)

Clinical Monograph for Drug Formulary Review: Systemic Agents for Psoriasis/Psoriatic Arthritis
por: Fisher, Vicki S.
Publicado: (2005)

Forecasting drug utilization and expenditure: ten years of experience in Stockholm
por: Linnér, Love, et al.
Publicado: (2020)

National Drug Formulary review of statin therapeutic group using the multiattribute scoring tool
por: Ramli, Azuana, et al.
Publicado: (2013)

Drug approval status and recommendations for listing on public formularies: a Canadian cohort analysis
por: Lexchin, Joel
Publicado: (2017)

Nonmedical switching of anticoagulants: The patient impact when formulary exclusions limit drug choice
por: Waldron, Beth
Publicado: (2022)

Evaluation of Clostridium difficile-Associated Diarrhea With a Drug Formulary Change in Preferred Fluoroquinolones
por: Walbrown, Molly A., et al.
Publicado: (2008)

General practitioners’ and nurses’ views on medication reviews and potentially inappropriate medicines in elderly patients – a qualitative study of reports by educating pharmacists
por: Schmidt-Mende, K., et al.
Publicado: (2018)

Drug and Medical Cost Effects of a Drug Formulary Change With Therapeutic Interchange for Statin Drugs in a Multistate Managed Medicaid Organization
por: Meissner, Brian, et al.
Publicado: (2006)

British national formulary /
Publicado: (2003)

Formulary for laboratory animals /
Publicado: (1999)

WHO model formulary
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_128h6lu0fr95lsukoitqlfrgas